EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology

Clémence Deligne iD, Arthur Tourbez, Flavie Bénard, Swann Meyer iD, Alexis Curt, Matteo Gianesello, Maud Hamadou, Léna Clavier, Claire Coquet, Charlotte Bocquet, Julia Tomine, Thomas Diot iD und 23 weitere

Neuro-Oncology · 21.06.2025 · 27 (5) · 1325-1340

DOI: 10.1093/neuonc/noaf007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 10.01.2025. Verfasst von Clémence Deligne und 34 weiteren Autor:innen. Beteiligte Einrichtung: Childhood Cancer & Cell Death Team (C3 Team), Consortium South-ROCK, LabEx DEVweCAN, Institut Convergence Plascan, Centre Léon Bérard, Centre de Rech…. Hauptthemen laut MEDLINE: Brain Neoplasms, Ependymoma, Biological Specimen Banks, Glioma. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ARCECI, SFCE, CLARA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Brain tumors are the deadliest solid tumors in children and adolescents. Most of these tumors are glial in origin and exhibit strong heterogeneity, hampering the development of effective therapeutic strategies. In the past decades, patient-derived tumor organoids (PDT-O) have emerged as powerful tools for modeling tumoral cell diversity and dynamics, and they could then help define new therapeutic options for pediatric brain tumors.

Methods

Through an integrative approach based on our expertise and a careful review of the literature about glioblastoma 3D primary cultures, we set up a standardized methodological pipeline for the establishment, characterization, and biobanking of PDT-O through direct 3D in vitro culture of the deadliest pediatric glial brain tumors. To assess PDT-O fidelity and validate their preclinical relevance, we performed comprehensive histological, molecular, and drug-response analyses.

Results

Our methodological pipeline allowed the rapid and efficient generation of PDT-O recapitulating their parental tumor features, including intratumoral heterogeneity, even after several passages and cryopreservation/revival as 3D cultures. Moreover, we successfully performed preclinical test responses on these PDT-O to standard-of-care therapies and new therapeutic options. Finally, we identified ONC201 as a selective drug for pediatric glial tumor types not restricted to H3K27-altered glial tumors, as well as combination strategies to increase the therapeutic response to ONC201.

Conclusions

Hence, we describe a fast and robust process to biobank PDT-O for pediatric glial brain tumors. These PDT-O models have the potential for patient-specific modeling even after long-term expansion in vitro, and we established the proof-of-concept of their usefulness to support powerful preclinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsEpendymomaBiological Specimen BanksGliomaOrganoidsAntineoplastic AgentsHumansChildAdolescentTumor Cells, CulturedNeoplasm Grading

Stichwörter der Autor:innen

drug combinationsependymomagliomapediatric brain tumortumor organoids

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Childhood Cancer & Cell Death Team (C3 Team), Consortium South-ROCK, LabEx DEVweCAN, Institut Convergence Plascan, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon (CRCL), Université Claude Bernard Lyon 1…
  • Armenise-Harvard Laboratory of Brain Disorders and Cancer, CIBIO, Trento, Italy.
  • Ribosome, Traduction and Cancer Team, LabEx DEVweCAN, Institut Convergence Plascan, LyriCAN+, Centre de Recherche en Cancérologie de Lyon (CRCL), INSERM U1052, CNRS UMR 5286, Centre Léon Bérard, Université de Lyon, Univ…
  • Department of Medical Biology and Pathological Anatomy, Hospices Civils de Lyon, 69777 Bron, France.
  • Department of Pediatric Oncology, Institut d'Hématologie et d'Oncologie Pédiatrique, Centre Léon Bérard, 69008 Lyon, France.
  • Research Pathology Platform East, CRCL, INSERM U1052-CNRS UMR5286, Centre Léon Bérard, Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.

ORCID-Profile: Clémence Deligne, Swann Meyer, Thomas Diot, Hermes Paraqindes, Virginie Marcel, Clément Berthelot, Marc Barritault, Clara Savary, Marc Billaud, Martine Cordier-Bussat, Pierre-Aurélien Beuriat, Alexandru Szathmari, Federico Di Rocco, Jean-Yves Blay, Alexandre Vasiljevic, David Meyronet, Marie Castets, Pierre Leblond, Laura Broutier

Förderung

  • ARCECI
  • SFCE
  • CLARA
  • Ligue Contre le Cancer
  • DevWeCan2 LabEx
  • Convergence Institute Plascan
  • ERiCAN
  • Fondation Neri

Zitieren

APA

Deligne, C., Tourbez, A., Bénard, F., Meyer, S., Curt, A., Gianesello, M., Hamadou, M., Clavier, L., Coquet, C., Bocquet, C., Tomine, J., Diot, T., Paraqindes, H., Marcel, V., Berthelot, C., Engel, J., Rochet, I., Barritault, M., Savary, C., …, & Broutier, L. (2025). Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology. Neuro-Oncology, 27(5), 1325-1340. https://doi.org/10.1093/neuonc/noaf007

Vancouver

Deligne C, Tourbez A, Bénard F, Meyer S, Curt A, Gianesello M, et al. Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology. Neuro-Oncology. 2025;27(5):1325-1340. doi:10.1093/neuonc/noaf007

BibTeX
@article{Deligne2025,
  author = {Deligne, Clémence and Tourbez, Arthur and Bénard, Flavie and Meyer, Swann and Curt, Alexis and Gianesello, Matteo and Hamadou, Maud and Clavier, Léna and Coquet, Claire and Bocquet, Charlotte and Tomine, Julia and Diot, Thomas and Paraqindes, Hermes and Marcel, Virginie and Berthelot, Clément and Engel, Justine and Rochet, Isabelle and Barritault, Marc and Savary, Clara and Gadot, Nicolas and Attignon, Valéry and Carrere, Marjorie and Billaud, Marc and Dutour, Aurélie and Cordier-Bussat, Martine and Beuriat, Pierre-Aurélien and Szathmari, Alexandru and Di Rocco, Federico and Blay, Jean-Yves and Tiberi, Luca and Vasiljevic, Alexandre and Meyronet, David and Castets, Marie and Leblond, Pierre and Broutier, Laura},
  title = {Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology},
  journal = {Neuro-Oncology},
  year = {2025},
  volume = {27},
  number = {5},
  pages = {1325--1340},
  doi = {10.1093/neuonc/noaf007}
}
Kostenlos starten →